May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
Refining Searches 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Corporate Financial December 21, 2012 Corporate Terumo Corporation announced strategic alliance with ChineseAngioCare in Renal Denervation Technology for Hypertension Treatment (PDF 443.54 KB) November 20, 2012 Corporate Harvest Technologies Corporation Granted CE Mark for Expanded Clinical Indication for Treatment of No-Option Critical Limb Ischemia October 05, 2012 Corporate Terumo Determined a Site for Construction of New Factory in Vietnam Investment in Expansion of the Blood Management Business October 02, 2012 Corporate Terumo Extends Licensing Agreement with Biosensors to Sell Nobori® DES System Incorporating BioMatrix™ Technology (PDF 72.47 KB) August 28, 2012 Corporate Terumo initiates clinical study to evaluate newly developed adhesion barrier product August 23, 2012 Corporate Terumo Joins the United Nations Global Compact August 01, 2012 Corporate Announcement regarding a Lawsuit for the Compensation of Damages against Olympus Corporation (PDF 10.76 KB) July 26, 2012 Corporate Notice on Today's Media Report (PDF 113.56 KB) June 04, 2012 Corporate Three-Year "NOBORI 2" Post Marketing Study Results Confirm Long-term Safety and Efficacy of Terumo's Nobori® Drug-Eluting Stent Positive Long-term Data from NOBORI 2 Presented at EuroPCR May 23, 2012 Corporate Terumo to Commence Sales of OFDI Intravascular Imaging System in Europe from July — Debuted at EuroPCR 2012, the World's Leading Cardiovascular Intervention Course — May 10, 2012 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2012 May 10, 2012 Corporate Terumo Expands Production in AsiaNew Factory Established and Existing Facilities Expanded in Vietnam and the Philippines May 07, 2012 Corporate Terumo Corporation establishes new sales branch in Austria April 02, 2012 Corporate CaridianBCT and Terumo Transfusion Become Terumo BCT Company Focuses on Commitment to Blood Banking, Transfusion Medicine and Cellular Therapies March 27, 2012 Corporate Terumo Establishes a Holding Company in Singapore March 19, 2012 Corporate Terumo Announces Strategic Business Alliance with Weigao in Peritoneal Dialysis Business March 05, 2012 Corporate NOBORI 2 study confirms efficacy and long-term safety of the Nobori® DES in daily practice February 29, 2012 Corporate Terumo Begins the World's First Clinical Study of Cardiac Regenerative Therapy Using Cell Sheets February 27, 2012 Corporate Regarding the Passing and Personnel Change of a Director February 23, 2012 Corporate Daiichi Sankyo and Terumo Announce Agreement for Co-development of Intradermal Vaccine for Infectious Disease February 23, 2012 Financial Terumo Corporation Announces Issuance of Unsecured Straight Bonds (PDF 61.58 KB) January 19, 2012 Corporate Terumo Corporation to Establish a New Production Factory in Yamaguchi Prefecture, Japan January 16, 2012 Corporate Terumo Americas Holding Acquires Onset Medical Corporation, A Leader In Innovative Sheath Technology Designed For Multiple, Minimally Invasive Clinical Applications Pagination Previous page ‹ Current page1 Next page ›
December 21, 2012 Corporate Terumo Corporation announced strategic alliance with ChineseAngioCare in Renal Denervation Technology for Hypertension Treatment (PDF 443.54 KB)
November 20, 2012 Corporate Harvest Technologies Corporation Granted CE Mark for Expanded Clinical Indication for Treatment of No-Option Critical Limb Ischemia
October 05, 2012 Corporate Terumo Determined a Site for Construction of New Factory in Vietnam Investment in Expansion of the Blood Management Business
October 02, 2012 Corporate Terumo Extends Licensing Agreement with Biosensors to Sell Nobori® DES System Incorporating BioMatrix™ Technology (PDF 72.47 KB)
August 28, 2012 Corporate Terumo initiates clinical study to evaluate newly developed adhesion barrier product
August 01, 2012 Corporate Announcement regarding a Lawsuit for the Compensation of Damages against Olympus Corporation (PDF 10.76 KB)
June 04, 2012 Corporate Three-Year "NOBORI 2" Post Marketing Study Results Confirm Long-term Safety and Efficacy of Terumo's Nobori® Drug-Eluting Stent Positive Long-term Data from NOBORI 2 Presented at EuroPCR
May 23, 2012 Corporate Terumo to Commence Sales of OFDI Intravascular Imaging System in Europe from July — Debuted at EuroPCR 2012, the World's Leading Cardiovascular Intervention Course —
May 10, 2012 Corporate Terumo Expands Production in AsiaNew Factory Established and Existing Facilities Expanded in Vietnam and the Philippines
April 02, 2012 Corporate CaridianBCT and Terumo Transfusion Become Terumo BCT Company Focuses on Commitment to Blood Banking, Transfusion Medicine and Cellular Therapies
March 19, 2012 Corporate Terumo Announces Strategic Business Alliance with Weigao in Peritoneal Dialysis Business
March 05, 2012 Corporate NOBORI 2 study confirms efficacy and long-term safety of the Nobori® DES in daily practice
February 29, 2012 Corporate Terumo Begins the World's First Clinical Study of Cardiac Regenerative Therapy Using Cell Sheets
February 23, 2012 Corporate Daiichi Sankyo and Terumo Announce Agreement for Co-development of Intradermal Vaccine for Infectious Disease
February 23, 2012 Financial Terumo Corporation Announces Issuance of Unsecured Straight Bonds (PDF 61.58 KB)
January 19, 2012 Corporate Terumo Corporation to Establish a New Production Factory in Yamaguchi Prefecture, Japan
January 16, 2012 Corporate Terumo Americas Holding Acquires Onset Medical Corporation, A Leader In Innovative Sheath Technology Designed For Multiple, Minimally Invasive Clinical Applications